Obesity Drug

1 article

Scientist in a lab with a vial of Pfizer's berobenatide, symbolizing a breakthrough in obesity treatment with potential for monthly dosing.

Pfizer's obesity drug shows potential for monthly dosing

Mid-stage study data reveals Pfizer's experimental obesity drug, berobenatide, could achieve significant weight loss with a groundbreaking monthly dosing schedule, a stark contrast to current weekly o

Aram Sarkisian·June 7, 2026